nodes	percent_of_prediction	percent_of_DWPC	metapath
Droxidopa—ADRB3—brown adipose tissue—metabolic syndrome X	0.154	0.346	CbGeAlD
Droxidopa—SLC6A2—sympathetic nervous system—metabolic syndrome X	0.0619	0.139	CbGeAlD
Droxidopa—SLC6A2—autonomic nervous system—metabolic syndrome X	0.0416	0.0935	CbGeAlD
Droxidopa—PAH—kidney—metabolic syndrome X	0.0296	0.0663	CbGeAlD
Droxidopa—ADRB3—adipose tissue—metabolic syndrome X	0.0208	0.0467	CbGeAlD
Droxidopa—PAH—liver—metabolic syndrome X	0.0187	0.0419	CbGeAlD
Droxidopa—DDC—kidney—metabolic syndrome X	0.0169	0.0378	CbGeAlD
Droxidopa—ADRA1B—kidney—metabolic syndrome X	0.0133	0.0298	CbGeAlD
Droxidopa—DDC—liver—metabolic syndrome X	0.0107	0.0239	CbGeAlD
Droxidopa—SLC16A10—adipose tissue—metabolic syndrome X	0.0104	0.0234	CbGeAlD
Droxidopa—ADRB1—cardiovascular system—metabolic syndrome X	0.00965	0.0217	CbGeAlD
Droxidopa—Mesalazine—PPARG—metabolic syndrome X	0.009	0.405	CrCbGaD
Droxidopa—ADRB1—adipose tissue—metabolic syndrome X	0.00851	0.0191	CbGeAlD
Droxidopa—ADRA1A—cardiovascular system—metabolic syndrome X	0.00763	0.0171	CbGeAlD
Droxidopa—SLC16A10—liver—metabolic syndrome X	0.00731	0.0164	CbGeAlD
Droxidopa—ADRA2C—kidney—metabolic syndrome X	0.00711	0.016	CbGeAlD
Droxidopa—ADRA1A—adipose tissue—metabolic syndrome X	0.00673	0.0151	CbGeAlD
Droxidopa—ADRA2C—adipose tissue—metabolic syndrome X	0.00641	0.0144	CbGeAlD
Droxidopa—ADRA2A—adipose tissue—metabolic syndrome X	0.00511	0.0115	CbGeAlD
Droxidopa—Aminosalicylic Acid—PTGS2—metabolic syndrome X	0.00484	0.218	CrCbGaD
Droxidopa—ADRA1A—liver—metabolic syndrome X	0.00472	0.0106	CbGeAlD
Droxidopa—Epinephrine—TNF—metabolic syndrome X	0.00461	0.207	CrCbGaD
Droxidopa—ADRA2C—liver—metabolic syndrome X	0.00449	0.0101	CbGeAlD
Droxidopa—Mesalazine—PTGS2—metabolic syndrome X	0.0038	0.171	CrCbGaD
Droxidopa—ADRA1B—Signaling Pathways—CYBA—metabolic syndrome X	0.000152	0.000285	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—PLA2G4A—metabolic syndrome X	0.000152	0.000285	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CNR1—metabolic syndrome X	0.000151	0.000284	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AGT—metabolic syndrome X	0.000151	0.000284	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—GHRL—metabolic syndrome X	0.000151	0.000284	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—HMGCR—metabolic syndrome X	0.000151	0.000283	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GOT2—metabolic syndrome X	0.000151	0.000283	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—GHRL—metabolic syndrome X	0.000149	0.000279	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IRS1—metabolic syndrome X	0.000148	0.000277	CbGpPWpGaD
Droxidopa—ADRA2A—Platelet activation, signaling and aggregation—AKT1—metabolic syndrome X	0.000145	0.000273	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOC3—metabolic syndrome X	0.000143	0.000269	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CNR1—metabolic syndrome X	0.000143	0.000269	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—TGFB1—metabolic syndrome X	0.000142	0.000267	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—INS—metabolic syndrome X	0.000141	0.000265	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CNR1—metabolic syndrome X	0.000141	0.000264	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AGT—metabolic syndrome X	0.00014	0.000264	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—CCL2—metabolic syndrome X	0.00014	0.000262	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000139	0.000262	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—CCL2—metabolic syndrome X	0.000139	0.000261	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF2—metabolic syndrome X	0.000139	0.000261	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000138	0.00026	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AGT—metabolic syndrome X	0.000137	0.000258	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IGF1—metabolic syndrome X	0.000137	0.000257	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—CCL2—metabolic syndrome X	0.000137	0.000257	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—APOB—metabolic syndrome X	0.000136	0.000255	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CYBA—metabolic syndrome X	0.000135	0.000253	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—APOB—metabolic syndrome X	0.000135	0.000253	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ABCA1—metabolic syndrome X	0.000134	0.000252	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—SLC2A4—metabolic syndrome X	0.000134	0.000252	CbGpPWpGaD
Droxidopa—PAH—Metabolism—AKT1—metabolic syndrome X	0.000133	0.00025	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—TGFB1—metabolic syndrome X	0.000133	0.000249	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PLA2G4A—metabolic syndrome X	0.000132	0.000248	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—GHRL—metabolic syndrome X	0.000132	0.000248	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL5—metabolic syndrome X	0.000131	0.000247	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000131	0.000246	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GGT1—metabolic syndrome X	0.00013	0.000244	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—GOT1—metabolic syndrome X	0.00013	0.000244	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—SERPINE1—metabolic syndrome X	0.00013	0.000244	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—LPL—metabolic syndrome X	0.00013	0.000244	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—HTR2C—metabolic syndrome X	0.000129	0.000243	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—CCL2—metabolic syndrome X	0.000129	0.000243	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LPL—metabolic syndrome X	0.000129	0.000242	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AGT—metabolic syndrome X	0.000128	0.00024	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—CCL2—metabolic syndrome X	0.000127	0.000239	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF2—metabolic syndrome X	0.000126	0.000237	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CYBA—metabolic syndrome X	0.000125	0.000235	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF2—metabolic syndrome X	0.000125	0.000235	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CNR1—metabolic syndrome X	0.000125	0.000235	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—NOS3—metabolic syndrome X	0.000124	0.000233	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF2—metabolic syndrome X	0.000124	0.000232	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—CD36—metabolic syndrome X	0.000123	0.000231	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—GHRL—metabolic syndrome X	0.000123	0.000231	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—APOB—metabolic syndrome X	0.000123	0.00023	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—APOB—metabolic syndrome X	0.000122	0.000228	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—APOB—metabolic syndrome X	0.00012	0.000225	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL5—metabolic syndrome X	0.00012	0.000225	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000119	0.000224	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL5—metabolic syndrome X	0.000119	0.000223	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000118	0.000222	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL5—metabolic syndrome X	0.000117	0.00022	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LPL—metabolic syndrome X	0.000117	0.00022	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF2—metabolic syndrome X	0.000117	0.00022	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000117	0.000219	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CNR1—metabolic syndrome X	0.000116	0.000218	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LPL—metabolic syndrome X	0.000116	0.000218	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF2—metabolic syndrome X	0.000115	0.000216	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LPL—metabolic syndrome X	0.000115	0.000215	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARA—metabolic syndrome X	0.000115	0.000215	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—APOB—metabolic syndrome X	0.000114	0.000213	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000113	0.000212	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—APOB—metabolic syndrome X	0.000112	0.00021	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AGT—metabolic syndrome X	0.000111	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL5—metabolic syndrome X	0.000111	0.000208	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.00011	0.000207	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—APOB—metabolic syndrome X	0.00011	0.000207	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AGT—metabolic syndrome X	0.00011	0.000207	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL5—metabolic syndrome X	0.000109	0.000205	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—PLA2G4A—metabolic syndrome X	0.000109	0.000204	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—APOE—metabolic syndrome X	0.000109	0.000204	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LPL—metabolic syndrome X	0.000108	0.000204	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—TGFB1—metabolic syndrome X	0.000108	0.000203	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—LEP—metabolic syndrome X	0.000108	0.000202	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—APOE—metabolic syndrome X	0.000108	0.000202	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—APOA1—metabolic syndrome X	0.000107	0.000202	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PLA2G4A—metabolic syndrome X	0.000107	0.000202	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LPL—metabolic syndrome X	0.000107	0.0002	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—APOA1—metabolic syndrome X	0.000107	0.0002	CbGpPWpGaD
Droxidopa—ADRB3—GPCR downstream signaling—AKT1—metabolic syndrome X	0.000106	0.0002	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—LPL—metabolic syndrome X	0.000105	0.000198	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—CCL2—metabolic syndrome X	0.000105	0.000197	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—IL6—metabolic syndrome X	0.000105	0.000196	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF2—metabolic syndrome X	0.000102	0.000192	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AGT—metabolic syndrome X	0.0001	0.000188	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—CD36—metabolic syndrome X	0.0001	0.000188	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AGT—metabolic syndrome X	9.93e-05	0.000187	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOB—metabolic syndrome X	9.92e-05	0.000186	CbGpPWpGaD
Droxidopa—ADRA2B—Hemostasis—AKT1—metabolic syndrome X	9.88e-05	0.000186	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—LEP—metabolic syndrome X	9.82e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—APOE—metabolic syndrome X	9.82e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AGT—metabolic syndrome X	9.8e-05	0.000184	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—LEP—metabolic syndrome X	9.73e-05	0.000183	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—APOE—metabolic syndrome X	9.73e-05	0.000183	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—APOA1—metabolic syndrome X	9.7e-05	0.000182	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL5—metabolic syndrome X	9.69e-05	0.000182	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—PLA2G4A—metabolic syndrome X	9.65e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRB3—Signaling by GPCR—AKT1—metabolic syndrome X	9.64e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—APOA1—metabolic syndrome X	9.62e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IRS1—metabolic syndrome X	9.61e-05	0.000181	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—APOE—metabolic syndrome X	9.6e-05	0.00018	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—LEP—metabolic syndrome X	9.6e-05	0.00018	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF2—metabolic syndrome X	9.5e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—APOA1—metabolic syndrome X	9.49e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LPL—metabolic syndrome X	9.48e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PPARG—metabolic syndrome X	9.46e-05	0.000178	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARA—metabolic syndrome X	9.3e-05	0.000175	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—INS—metabolic syndrome X	9.28e-05	0.000174	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AGT—metabolic syndrome X	9.27e-05	0.000174	CbGpPWpGaD
Droxidopa—ADRA2C—Hemostasis—AKT1—metabolic syndrome X	9.23e-05	0.000173	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOB—metabolic syndrome X	9.22e-05	0.000173	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—INS—metabolic syndrome X	9.2e-05	0.000173	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AGT—metabolic syndrome X	9.13e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—LEP—metabolic syndrome X	9.09e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—APOE—metabolic syndrome X	9.09e-05	0.000171	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—CCL2—metabolic syndrome X	9.06e-05	0.00017	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AGT—metabolic syndrome X	9.01e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL5—metabolic syndrome X	9e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—APOA1—metabolic syndrome X	8.98e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—PLA2G4A—metabolic syndrome X	8.97e-05	0.000169	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—LEP—metabolic syndrome X	8.94e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—APOE—metabolic syndrome X	8.94e-05	0.000168	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IGF1—metabolic syndrome X	8.9e-05	0.000167	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—APOA1—metabolic syndrome X	8.84e-05	0.000166	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—APOE—metabolic syndrome X	8.83e-05	0.000166	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LPL—metabolic syndrome X	8.8e-05	0.000165	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IRS1—metabolic syndrome X	8.76e-05	0.000165	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—APOA1—metabolic syndrome X	8.72e-05	0.000164	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IRS1—metabolic syndrome X	8.68e-05	0.000163	CbGpPWpGaD
Droxidopa—DDC—Metabolism—AKT1—metabolic syndrome X	8.61e-05	0.000162	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IRS1—metabolic syndrome X	8.57e-05	0.000161	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—ALB—metabolic syndrome X	8.51e-05	0.00016	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—SERPINE1—metabolic syndrome X	8.45e-05	0.000159	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—INS—metabolic syndrome X	8.39e-05	0.000158	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—INS—metabolic syndrome X	8.31e-05	0.000156	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—CCL2—metabolic syndrome X	8.25e-05	0.000155	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—INS—metabolic syndrome X	8.2e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—TGFB1—metabolic syndrome X	8.19e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—CCL2—metabolic syndrome X	8.18e-05	0.000154	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—NOS3—metabolic syndrome X	8.14e-05	0.000153	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IGF1—metabolic syndrome X	8.11e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AGT—metabolic syndrome X	8.11e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IRS1—metabolic syndrome X	8.11e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—CCL2—metabolic syndrome X	8.07e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—NOS3—metabolic syndrome X	8.07e-05	0.000152	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IGF1—metabolic syndrome X	8.04e-05	0.000151	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IRS1—metabolic syndrome X	7.98e-05	0.00015	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—LEP—metabolic syndrome X	7.94e-05	0.000149	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOE—metabolic syndrome X	7.94e-05	0.000149	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IGF1—metabolic syndrome X	7.93e-05	0.000149	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—APOA1—metabolic syndrome X	7.85e-05	0.000148	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—INS—metabolic syndrome X	7.76e-05	0.000146	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—SERPINE1—metabolic syndrome X	7.7e-05	0.000145	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PPARG—metabolic syndrome X	7.69e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—INS—metabolic syndrome X	7.64e-05	0.000144	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—CCL2—metabolic syndrome X	7.64e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—SERPINE1—metabolic syndrome X	7.63e-05	0.000143	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—INS—metabolic syndrome X	7.54e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—SERPINE1—metabolic syndrome X	7.54e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AGT—metabolic syndrome X	7.53e-05	0.000142	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—CCL2—metabolic syndrome X	7.52e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IGF1—metabolic syndrome X	7.51e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA2A—Hemostasis—AKT1—metabolic syndrome X	7.5e-05	0.000141	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—PTGS2—metabolic syndrome X	7.45e-05	0.00014	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IGF1—metabolic syndrome X	7.39e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOE—metabolic syndrome X	7.38e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—LEP—metabolic syndrome X	7.38e-05	0.000139	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—NOS3—metabolic syndrome X	7.35e-05	0.000138	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—APOA1—metabolic syndrome X	7.3e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—NOS3—metabolic syndrome X	7.29e-05	0.000137	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—NOS3—metabolic syndrome X	7.19e-05	0.000135	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—SERPINE1—metabolic syndrome X	7.13e-05	0.000134	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IRS1—metabolic syndrome X	7.09e-05	0.000133	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—SERPINE1—metabolic syndrome X	7.02e-05	0.000132	CbGpPWpGaD
Droxidopa—ADRA1D—GPCR downstream signaling—AKT1—metabolic syndrome X	6.92e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—ALB—metabolic syndrome X	6.91e-05	0.00013	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—IL6—metabolic syndrome X	6.81e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—NOS3—metabolic syndrome X	6.81e-05	0.000128	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—INS—metabolic syndrome X	6.79e-05	0.000127	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—NOS3—metabolic syndrome X	6.7e-05	0.000126	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—CCL2—metabolic syndrome X	6.68e-05	0.000125	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—NOS3—metabolic syndrome X	6.61e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IRS1—metabolic syndrome X	6.58e-05	0.000124	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IGF1—metabolic syndrome X	6.56e-05	0.000123	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—INS—metabolic syndrome X	6.3e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRB1—GPCR downstream signaling—AKT1—metabolic syndrome X	6.3e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling by GPCR—AKT1—metabolic syndrome X	6.28e-05	0.000118	CbGpPWpGaD
Droxidopa—ADRA2B—GPCR downstream signaling—AKT1—metabolic syndrome X	6.24e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—SERPINE1—metabolic syndrome X	6.23e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—IL6—metabolic syndrome X	6.2e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—CCL2—metabolic syndrome X	6.2e-05	0.000117	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—IL6—metabolic syndrome X	6.17e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRB2—GPCR downstream signaling—AKT1—metabolic syndrome X	6.16e-05	0.000116	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—IL6—metabolic syndrome X	6.15e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IGF1—metabolic syndrome X	6.1e-05	0.000115	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—IL6—metabolic syndrome X	6.07e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—PTGS2—metabolic syndrome X	6.05e-05	0.000114	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—NOS3—metabolic syndrome X	5.95e-05	0.000112	CbGpPWpGaD
Droxidopa—ADRA2C—GPCR downstream signaling—AKT1—metabolic syndrome X	5.83e-05	0.00011	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—SERPINE1—metabolic syndrome X	5.79e-05	0.000109	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—IL6—metabolic syndrome X	5.74e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRA1B—GPCR downstream signaling—AKT1—metabolic syndrome X	5.74e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRB1—Signaling by GPCR—AKT1—metabolic syndrome X	5.72e-05	0.000108	CbGpPWpGaD
Droxidopa—ADRB3—Signaling Pathways—AKT1—metabolic syndrome X	5.7e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling by GPCR—AKT1—metabolic syndrome X	5.67e-05	0.000107	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—IL6—metabolic syndrome X	5.65e-05	0.000106	CbGpPWpGaD
Droxidopa—ADRB2—Signaling by GPCR—AKT1—metabolic syndrome X	5.6e-05	0.000105	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—NOS3—metabolic syndrome X	5.53e-05	0.000104	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—TGFB1—metabolic syndrome X	5.34e-05	0.0001	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling by GPCR—AKT1—metabolic syndrome X	5.3e-05	9.95e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling by GPCR—AKT1—metabolic syndrome X	5.21e-05	9.8e-05	CbGpPWpGaD
Droxidopa—ADRA1A—GPCR downstream signaling—AKT1—metabolic syndrome X	5.1e-05	9.58e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—IL6—metabolic syndrome X	5.02e-05	9.43e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—TGFB1—metabolic syndrome X	4.86e-05	9.14e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—TGFB1—metabolic syndrome X	4.82e-05	9.05e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—TGFB1—metabolic syndrome X	4.76e-05	8.94e-05	CbGpPWpGaD
Droxidopa—ADRA2A—GPCR downstream signaling—AKT1—metabolic syndrome X	4.74e-05	8.9e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—IL6—metabolic syndrome X	4.66e-05	8.76e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling by GPCR—AKT1—metabolic syndrome X	4.63e-05	8.7e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—TGFB1—metabolic syndrome X	4.5e-05	8.46e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—TGFB1—metabolic syndrome X	4.43e-05	8.32e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling by GPCR—AKT1—metabolic syndrome X	4.3e-05	8.08e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—IL6—metabolic syndrome X	4.02e-05	7.56e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—TGFB1—metabolic syndrome X	3.93e-05	7.39e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Metabolism—AKT1—metabolic syndrome X	3.74e-05	7.03e-05	CbGpPWpGaD
Droxidopa—ADRA1D—Signaling Pathways—AKT1—metabolic syndrome X	3.71e-05	6.97e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—IL6—metabolic syndrome X	3.66e-05	6.89e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—TGFB1—metabolic syndrome X	3.66e-05	6.87e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—IL6—metabolic syndrome X	3.63e-05	6.82e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—IL6—metabolic syndrome X	3.58e-05	6.74e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—IL6—metabolic syndrome X	3.39e-05	6.37e-05	CbGpPWpGaD
Droxidopa—ADRB1—Signaling Pathways—AKT1—metabolic syndrome X	3.38e-05	6.35e-05	CbGpPWpGaD
Droxidopa—ADRA2B—Signaling Pathways—AKT1—metabolic syndrome X	3.35e-05	6.29e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—IL6—metabolic syndrome X	3.34e-05	6.27e-05	CbGpPWpGaD
Droxidopa—ADRB2—Signaling Pathways—AKT1—metabolic syndrome X	3.31e-05	6.21e-05	CbGpPWpGaD
Droxidopa—ADRA2C—Signaling Pathways—AKT1—metabolic syndrome X	3.13e-05	5.88e-05	CbGpPWpGaD
Droxidopa—ADRA1B—Signaling Pathways—AKT1—metabolic syndrome X	3.08e-05	5.79e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Metabolism—AKT1—metabolic syndrome X	3.04e-05	5.71e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—IL6—metabolic syndrome X	2.96e-05	5.57e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—IL6—metabolic syndrome X	2.75e-05	5.18e-05	CbGpPWpGaD
Droxidopa—ADRA1A—Signaling Pathways—AKT1—metabolic syndrome X	2.74e-05	5.14e-05	CbGpPWpGaD
Droxidopa—ADRA2A—Signaling Pathways—AKT1—metabolic syndrome X	2.54e-05	4.78e-05	CbGpPWpGaD
